Surrogate endpoints in global health research: still searching for killer apps and silver bullets?
نویسندگان
چکیده
منابع مشابه
Use of Surrogate end points in HTA
The different actors involved in health system decision-making and regulation have to deal with the question which are valid parameters to assess the health value of health technologies.So called surrogate endpoints represent in the best case preliminary steps in the casual chain leading to the relevant outcome (e. g. mortality, morbidity) and are not usually directly perceptible by patients. S...
متن کاملTowards a Killer App for the Semantic Web
Killer apps are highly transformative technologies that create new markets and widespread patterns of behaviour. IT generally, and the Web in particular, has benefited from killer apps to create new networks of users and increase its value. The Semantic Web community on the other hand is still awaiting a killer app that proves the superiority of its technologies. There are certain features that...
متن کاملKiller Apps: Developing Novel Applications That Enhance Team Coordination, Communication, and Effectiveness
As part of the Lorentz workshop, "Interdisciplinary Insights into Group and Team Dynamics," held in Leiden, Netherlands, this article describes how Geeks and Groupies (computer and social scientists) may benefit from interdisciplinary collaboration toward the development of killer apps in team contexts that are meaningful and challenging for both. First, we discuss interaction processes during ...
متن کاملINTRODUCTION AND DEVELOPMENT OF SURROGATE MANAGEMENT FRAMEWORK FOR SOLVING OPTIMIZATION PROBLEMS
In this paper, we have outlined the surrogate management framework for optimization of expensive functions. An initial simple iterative method which we call the “Strawman” method illustrates how surrogates can be incorporated into optimization to stand in for the most expensive function. These ideas are made rigorous by incorporating them into the framework of pattern search methods. The SMF al...
متن کاملAbstracts of the NIH-FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications”
s of the NIH-FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications” Abstracts of the NIH-FDA Conference 188s of the NIH-FDA Conference 188
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 3 شماره
صفحات -
تاریخ انتشار 2018